The kids are playing computer games. According to the latest Global Games Market Report from the analysts at industry intelligence firm Newzoo, Gen Alpha—defined in this case as anyone born in or ...

A certain kind of person is going to fall completely in love with Vampire: The Masquerade - Bloodlines 2. Playing through a new hands-on demo showing off more of its dark vision of Seattle, I'm struck ...

October 1, 2025: Get around 200k cash and some Gold keys with the current King Legacy codes list. Looking for new King Legacy codes? The Roblox gacha game is one of the most popular on the platform ...

For a long time, Sarah Michelle Gellar has denied any desire to return to her role as “The Chosen One,” Buffy Anne Summers. But recently, Gellar said she might be interested, thanks to the success of ...

In Ink Game, Vampire is a Power that lets you embody the bloodthirsty entity of the same name. This Power has been assigned the Mythic rarity, making it one of the most elusive ability sets in the ...

ePHOTOzine brings you a daily round up of all the latest photography news including camera news, exhibitions, events, special offers, industry news, digital photography news, announcements and ...

The two Vampire: The Masquerade - Bloodlines 2 clans that were set to launch as paid DLC will now be included in the base game. The long-awaited sequel is just one month out, but has been mired in ...

In this section you'll find photographic features that explore holidays and photography courses, details about members meetings, trials and tribulations of installing new software along with general ...

Creators who make content for Fortnite can start monetizing their virtual goods in December. The free-to-play online game's publisher, Epic Games, announced that those in its Creator program will earn ...

Can you even imagine a game that combines Pokémon with a Survivors-like? You don’t need to imagine it, because developer Lioncode Games is making it. Wildkeepers Rising is a roguelike “bullet heaven” ...

Dr Maurie Markman discusses a recent study focused on immunotherapy in the inpatient setting for patients with stage IV cancer.